View Cart (0 items)
FDA approves NxStage's System One for home nocturnal hemodialysis

NxStage's System One is the only hemodialysis machine cleared by the FDA for this indication

Researchers find way to suppress inflammation during dialysis treatments

University of Pennsylvania researchers have found a way to avoid the systemic inflammation common in dialysis patients by temporarily suppressing complement during dialysis treatments

DSI Renal hires bank to look at options

The dialysis provider is working on the sale with Moelis & Co, according to The Wall Street Journal

WHAT'S NEW

Rss
Rss

Blogs

Dear Senators

Dear Senators

Among all nations on earth, there is no other as close to the US in character, living standard, and lifestyle as is Australia. We are two peas in a pod! Well, we are, except for the way we manage healthcare and how we do dialysis.

More
Slow FDA response is hurting nocturnal home HD

Slow FDA response is hurting nocturnal home HD

It’s been about four years since NxStage submitted the System One cycler to the FDA to try to get a new indication for nocturnal home use. Four years. An entire Presidency’s worth of delays, additional studies, conference calls—and more delays.

More

WHAT'S NEW

Rss
Rss

Blogs

Dear Senators

Dear Senators

Among all nations on earth, there is no other as close to the US in character, living standard, and lifestyle as is Australia. We are two peas in a pod! Well, we are, except for the way we manage healthcare and how we do dialysis.

More
Slow FDA response is hurting nocturnal home HD

Slow FDA response is hurting nocturnal home HD

It’s been about four years since NxStage submitted the System One cycler to the FDA to try to get a new indication for nocturnal home use. Four years. An entire Presidency’s worth of delays, additional studies, conference calls—and more delays.

More